Personalis Forms Research Collaboration to Better Predict Immunotherapy Response for Gastroesophageal Cancer Oct 4, 2022 09:00AM
Standard BioTools Announces Second Quarter 2022 Financial Results and Provides Strategic Update Aug 8, 2022 04:02PM
Fluidigm Announces Third Quarter 2021 Financial Results Nov 8, 2021 04:02PM